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Background: Previous studies have shown that sodium chloride (SC) or sodium bicarbonate (SB) administration before contrast media injection 
reduces the risk of contrast-induced nephropathy. However, we couldn’t have any time to administrate sufficient fluid injection in an emergent case 
with chronic kidney disease (CKD) such as acute coronary syndrome. There is no information available on the effect of the bolus injection with SB in 
an emergent case with CKD. 
Methods: We enrolled 38 patients with CKD (serum creatinine>1.1mg/dl or estimated glomerular filtration rate (eGFR) by the MDRD 
equation<60ml/min/1.73m2), who underwent an emergent coronary angiography or intervention. They were randomized to receive an infusion of 
either SC (n=20) or SB (n=18), as a bolus of 0.5ml/kg just before the administration of contrast media injection, followed by an infusion of 1 ml/
kg/h sodium bicarbonate for 6 hours during and after the procedure. Serum creatinine level was measured at baseline and 2 days after the contrast 
media administration. 
Results: There were no significant differences in age, sex, incidence of diabetes mellitus, contrast volume, left ventricular ejection fraction and the 
baseline serum creatinine level between the two groups. Serum creatinine level remained unchanged in SB group (1.21±0.26 to 1.07±0.28mg/dl, 
P=0.18), although it significantly increased (1.49±0.67 to 1.76±1.35mg/dl, P<0.05) 2 days after the contrast media administration in SC group. 
Conclusion: In patients with chronic kidney disease undergoing an emergent coronary procedure, bolus injection with SB would preserve short-
term renal function.
